GlassScriptPhysician profile
Frederick Walter Funke
NPI 1437357274
$10,567.03
in general payments reported to CMS, 2019-2025
40 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,953 · 2020: $1,844 · 2021: $1,344 · 2022: $1,690 · 2023: $1,429 · 2024: $1,674 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,736.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,679.37 | 2019-2025 | Aveir, Jot Dx, Assurity |
| Boston Scientific Corporation | $1,144.67 | 2019-2025 | Avvigo Guidance System, Opticross, Rotablator Rotational Atherectomy System Console Kit |
| E.R. Squibb & Sons, L.L.C. | $682.81 | 2019-2024 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $663.29 | 2019-2023 | Farxiga |
| Medtronic Vascular, INC. | $564.09 | 2019-2020 | |
| Inari Medical, INC. | $533.90 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.66 | 2019-2024 | Jardiance |
| Cardiva Medical, INC. | $461.07 | 2021-2025 | Savvywire, Cardiva Vascade 6/7f Vcs, Optowire |
| Philips North America LLC | $448.81 | 2023-2025 | (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und, Ecc Solutions |
| Novartis Pharmaceuticals Corporation | $388.72 | 2019-2024 | |
| Medtronic, INC. | $365.59 | 2021-2025 | Azure Xt Dr Mri Surescan, Na, Tyrx |
| Amgen INC. | $351.85 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $350.67 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $312.30 | 2019-2021 | |
| Pfizer INC. | $282.93 | 2019-2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $164.20 | 2021-2022 | |
| Abiomed | $142.58 | 2019 | |
| Livanova USA, INC. | $132.93 | 2019 | |
| Endologix LLC | $122.36 | 2022 | |
| Teleflex LLC | $116.97 | 2023-2024 | Langston, Manta, Turnpike |
| Astellas Pharma US INC | $114.46 | 2019-2020 | |
| Edwards Lifesciences Corporation | $113.49 | 2020-2025 | Sapien 3 Ultra Resilia |
| Biotronik INC. | $101.51 | 2019-2024 | Amvia Edge, Biomonitor |
| Alnylam Pharmaceuticals INC. | $98.69 | 2021-2024 | Onpattro |
| Irhythm Technologies, INC. | $89.54 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $86.90 | 2019-2023 | Praluent, Evkeeza |
| Kiniksa Pharmaceuticals, LTD. | $77.77 | 2022-2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $74.95 | 2019-2023 | |
| Esperion Therapeutics, INC. | $73.53 | 2021-2023 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $69.58 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $60.43 | 2024 | Arcalyst |
| Cvrx, INC. | $51.79 | 2023 | Barostim Neo System |
| Scpharmaceuticals INC. | $38.59 | 2024 | |
| Heartflow, INC. | $36.05 | 2019 | |
| Atricure, INC. | $23.20 | 2022 | |
| Shockwave Medical, INC | $18.55 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Preventice Services, LLC | $17.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.88 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $17.21 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Funke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.